Last reviewed · How we verify

NCT03354793

Endometriosis and Risk of Obstetric Complications

Completed Last updated 28 November 2017
What this trial tests

trial testing Survey on first pregnancy after endometriosis diagnosis in Endometriosis in 844 participants. Completed in 4 October 2017.

Timeline
15 January 2016
Primary endpoint
4 October 2017
4 October 2017

Quick facts

Lead sponsorEndometriosis Treatment Italian Club
StatusCompleted
Study typeOBSERVATIONAL
Enrollment844
Start date15 January 2016
Primary completion4 October 2017
Estimated completion4 October 2017

Drugs / interventions tested

Conditions studied

Sponsor

Endometriosis Treatment Italian Club

Who can join

Adults 30 to 50, female only, with Endometriosis or Pregnancy Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the rate of obstetric complications at first spontaneous pregnancy among women with endometriosis, with the rate of obstetric complications at first spontaneous pregnancy among women without endometriosis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study.
    Berlanda N, Alio W, Angioni S, Bergamini V, et al · · 2022 · cited 26× · PMID 34623489 · DOI 10.1007/s00404-021-06243-z

Verify or expand the search:

Other trials of Survey on first pregnancy after endometriosis diagnosis

Trials testing the same drug.

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Endometriosis Treatment Italian Club trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03354793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing